First-line treatment of Waldenstrom's disease with cladribine

Annals of Hematology

Volumn 74, Issue 1, 1997, Pages 7-10

  Fridrik, M A ^a   Jager G ^b   Baldinger, C ^c   Krieger, O ^a   Chott, A ^d   Bettelheim, P ^e  

^a Departments of Internal Medicine   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c Third Department of Medicine   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

^e Central Laboratory   (Austria)

Author keywords

2 CdA; Low grade NHL; Treatment; Waldenstrom's disease

Indexed keywords

ALPHA2 INTERFERON; ALPHA2C INTERFERON; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; EPIRUBICIN; PARACETAMOL; PREDNIMUSTINE; PREDNISOLONE; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FLU LIKE SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; MALE; MULTICENTER STUDY; NEUTROPENIA; OPPORTUNISTIC INFECTION; PERTHES DISEASE; PRIORITY JOURNAL; STATISTICS; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CLADRIBINE; FEMALE; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; NEUTROPENIA; PROSPECTIVE STUDIES; REMISSION INDUCTION; WALDENSTROM MACROGLOBULINEMIA;

EID: 1842406646     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050247     Document Type: Article

References (13)

1. Betticher DC, Egger T, van der Rohr A, Sonderegger T, Zulian G, Frey MF, Cerny T (1996) 2-Chlorodeoxyadenosine (2-CDA) in pretreated low-grade non-Hodgkin's lymphoma (NHL) patients: lower frequency of infections with maintained high response rate after dose reduction. Ann Oncol 7 [Suppl 3]:67 (abstract)
2. Carson DA, Wasson DB, Teatle R, Yu A (1983) A specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood 62:737-743
3. Case DC, Ervin TJ, Boyd MA (1993) Long term results and disease characteristics of patients with Waldenströms macroglobulinemia treated with the M-2 protocol. Blood 82:561 [Suppl 1]
4. Dimipopoulos MA, Kantarjian HM, Estey EH, O'Brien S, Dellasalle K, Keating MJ, Freireich EJ, Alexanian R (1993) Treatment of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine. Ann Intern Med 118:195-198
5. Dimipopoulos MA, Kantarjian HM, Weber D, O'Brian S, Estey EH, Delasalle K, Rose E, Cabanillas F, Keating M, Alexanian R (1994) Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine. J Clin Oncol 12:2694-2698
6. Harris NL, Jaffe ES, Stein H, Banks PM, Chan KC, Cleary ML, Delsol G, De Wolf-Peters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowels DM, Mason DY, Müller-Hermelik HK, Pieri SA, Piris MA, Kalfkiaer E, Warnke RA (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361-1392
7. Horsman DE, Card RT, Skinnider LF (1983) Waldenström's macroglobulinemia terminating in acute leukemia. Am J Hematol 15:97-101
8. Kyle RA, Garton JP (1987) The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc 62:719-731
9. Mackenzie MR, Fudenberg HH (1972) Macroglobulinemia: an analysis of forty patients. Blood 39:874-889
10. Petrucci MT, Avisati G, Tribalto (1989) Waldenström's macroglobulinemia: results of a combined oral treatment in 34 newly diagnosed patients. J Intern Med 226:443-447
11. Smalley RV, Andersen JW, Hawkins MJ, Bhide V, O'Connell MJ, Oken MM, Borden MD (1992) Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma. N Engl J Med 327:1336-1341
12. Solal-Celigny P, Lepage E, Brousse N, Reyes F, Haioun M, Leporrier M, Peuchmaur M, Bosly A, Parlier Y, Brice P, Coiffier B, Gisselbrecht C (1993) Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. N Engl J Med 329:1608-1614
13. Waldenström J (1944) Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia - a new syndrome? Acta Med Scand 117:216-222